Sponsors (41)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
The bill aims to reduce political influence over NIH funding and clarify who counts as a political employee—improving merit-based research decisions and transparency—while increasing reclassification risk and administrative/legal constraints that could hinder managerial flexibility and rapid responses to problematic awards.
Federal agencies (including NIH) get a clearer statutory definition of who is a "political employee," letting agencies apply ethics, recusals, and appointment rules more consistently.
Researchers, hospitals, and the scientific community will face fewer politically motivated management and grant decisions because political employees are barred from grant solicitation, review, scoring, selection, and awarding, supporting merit-based funding.
Grant recipients and the public gain more transparency and procedural protections: NIH must report past political involvement and agencies must provide written findings and notify relevant committees before suspending or cancelling awards, which helps keep awards running absent clear fraud or mismanagement.
Career civil servants and contractors who do policy work could be reclassified as "political employees," reducing hiring protections and creating new administrative tracking burdens for agencies.
NIH's prohibition on most political appointees (other than the three named directors) may shrink the pool of experienced political managers and complicate interagency coordination, reducing administrative flexibility for program implementation.
Limiting HHS/NIH's ability to quickly pause or stop problematic awards and overriding existing grant-management rules could delay corrective actions for fraud or safety issues, raise program management costs, and create legal uncertainty about enforcement of uniform financial controls.
Introduced January 21, 2026 by Diana DeGette · Last progress January 21, 2026
Prohibits a defined class of "political employees" from being employed in management or policy roles at the National Institutes of Health (with narrow exceptions) and from participating in NIH or ARPA-H grant, contract, or award decisions. It also limits the Department of Health and Human Services' ability to cancel, suspend, or delay awarded agreements absent written findings of fraud, mismanagement, debarment, or malfeasance and requires prompt notice to congressional committees. The NIH Director must report to Congress within 30 days on political-employee participation in funding decisions since January 20, 2021. The bill defines which federal positions count as "political employees," preserves certain statutory requirements, and explicitly overrides some regulatory authority to enforce that awarded agreements be carried out under their terms unless the two-step cancellation process is followed.